Rumination and Overrecruitment of Cognitive Control Circuits in Depression
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · 2024-08 · 9 (8) · 800-808
DOI: 10.1016/j.bpsc.2024.04.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2024-08. Verfasst von Heekyeong Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laureate Institute for Brain Research, Tulsa, Oklahoma; Department of Psychology, University of North Texas at Dallas, Dallas, Texas. Electronic addr…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Rumination, Cognitive, Major Depressive Disorder, Inhibition, Psychological. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDA NIH HHS, National Institute on Drug Abuse.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Rumination is associated with greater cognitive dysfunction and treatment resistance in major depressive disorder (MDD), but its underlying neural mechanisms are not well understood. Because rumination is characterized by difficulty in controlling negative thoughts, the current study investigated whether rumination was associated with aberrant cognitive control in the absence of negative emotional information. METHODS: Individuals with MDD (n = 176) and healthy control individuals (n = 52) completed the stop signal task with varied stop signal difficulty during functional magnetic resonance imaging. In the task, a longer stop signal asynchrony made stopping difficult (hard stop), whereas a shorter stop signal asynchrony allowed more time for stopping (easy stop). RESULTS: In participants with MDD, higher rumination intensity was associated with greater neural activity in response to difficult inhibitory control in the frontoparietal regions. Greater activation for difficult inhibitory control associated with rumination was also positively related to state fear. The imaging results provide compelling evidence for the neural basis of inhibitory control difficulties in individuals with MDD with high rumination. CONCLUSIONS: The association between higher rumination intensity and greater neural activity in regions involved in difficult inhibitory control tasks may provide treatment targets for interventions aimed at improving inhibitory control and reducing rumination in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laureate Institute for Brain Research, Tulsa, Oklahoma; Department of Psychology, University of North Texas at Dallas, Dallas, Texas. Electronic address: Heekyeong.Park@untdallas.edu.
- Laureate Institute for Brain Research, Tulsa, Oklahoma.
- Laureate Institute for Brain Research, Tulsa, Oklahoma; Oxley College of Health Science, University of Tulsa, Tulsa, Oklahoma.
- Laureate Institute for Brain Research, Tulsa, Oklahoma; Department of Psychiatry, Oklahoma State University Health Sciences Center, Tulsa, Oklahoma.
Förderung
- NIGMS NIH HHS
- NIDA NIH HHS
- National Institute on Drug Abuse
- William K Warren Foundation
- National Institute of General Medical Sciences
Zitieren
APA
Park, H., Kuplicki, R., Paulus, M. P., & Guinjoan, S. M. (2024). Rumination and Overrecruitment of Cognitive Control Circuits in Depression. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 9(8), 800-808. https://doi.org/10.1016/j.bpsc.2024.04.013
Vancouver
Park H, Kuplicki R, Paulus MP, Guinjoan SM. Rumination and Overrecruitment of Cognitive Control Circuits in Depression. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2024;9(8):800-808. doi:10.1016/j.bpsc.2024.04.013
BibTeX
@article{Park2024,
author = {Park, Heekyeong and Kuplicki, Rayus and Paulus, Martin P and Guinjoan, Salvador M},
title = {Rumination and Overrecruitment of Cognitive Control Circuits in Depression},
journal = {Biological Psychiatry: Cognitive Neuroscience and Neuroimaging},
year = {2024},
volume = {9},
number = {8},
pages = {800--808},
doi = {10.1016/j.bpsc.2024.04.013}
}
EUVIMED